Published in Gastrointest Cancer Res on July 01, 2008
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (2000) 64.32
Untangling the ErbB signalling network. Nat Rev Mol Cell Biol (2001) 28.05
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell (2006) 27.36
The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol (2004) 24.63
Hepatocellular carcinoma. Lancet (2003) 22.54
Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med (1999) 17.03
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell (2006) 16.05
Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet (2002) 7.67
Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer (1985) 7.67
Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology (2004) 6.98
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell (2002) 6.64
A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology (1998) 6.47
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med (2006) 6.31
Hepatocellular carcinoma: recent trends in the United States. Gastroenterology (2004) 5.90
Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology (1999) 5.64
High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients. Cancer Cell (2006) 5.01
In situ analyses of genome instability in breast cancer. Nat Genet (2004) 4.32
Application of comparative functional genomics to identify best-fit mouse models to study human cancer. Nat Genet (2004) 3.97
Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53. Cell (2003) 3.92
Focus on hepatocellular carcinoma. Cancer Cell (2004) 3.49
c-jun is essential for normal mouse development and hepatogenesis. Nature (1993) 3.43
Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology (2004) 3.30
Cancer modeling in the modern era: progress and challenges. Cell (2002) 3.12
In vivo eradication of human BCR/ABL-positive leukemia cells with an ABL kinase inhibitor. J Natl Cancer Inst (1999) 2.81
A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire. J Hepatol (1999) 2.38
Mechanisms of drug inhibition of signalling molecules. Nature (2006) 2.27
Functional genomics of hepatocellular carcinoma. Hepatology (2006) 2.02
Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors. Hum Mol Genet (2004) 1.80
Genome-scale profiling of gene expression in hepatocellular carcinoma: classification, survival prediction, and identification of therapeutic targets. Gastroenterology (2004) 1.71
Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients. Hepatology (1990) 1.52
Functional and genomic implications of global gene expression profiles in cell lines from human hepatocellular cancer. Hepatology (2002) 1.51
Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome. Blood (2005) 1.51
Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival. Cell Oncol (2004) 1.46
Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice. Gastroenterology (2004) 1.35
Molecular prognostication of liver cancer: end of the beginning. J Hepatol (2006) 1.12
Nonrandom cytogenetic alterations in hepatocellular carcinoma from transgenic mice overexpressing c-Myc and transforming growth factor-alpha in the liver. Am J Pathol (1999) 1.09
Studying cancer in the mouse. Oncogene (1999) 1.03
Comparative functional genomics for identifying models of human cancer. Carcinogenesis (2005) 1.02
Simple clinical prognostic model for hepatocellular carcinoma in developing countries and its validation. J Clin Oncol (2003) 1.00
Genetic profiling of human hepatocellular carcinoma. Semin Liver Dis (2005) 0.99
Herceptin raises its sights beyond advanced breast cancer. J Natl Cancer Inst (1998) 0.80
Genomic decoding of hepatocellular carcinoma. Gastroenterology (2006) 0.80